Schedule 13G ownership disclosure
DIPEXIUM PHARMACEUTICALS INC
Security class unavailable · CUSIP: 25456J104
Event date: 2017-04-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-17-007644
- Form type
- SC 13G
- Filer
- PLx Pharma Inc.
- CIK
- CIK 1497504
- Filed
- May 01, 2017
- Reporting period
- Apr 19, 2017
- Description
- Schedule 13G beneficial ownership